Literature DB >> 11429551

CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter.

G W Beresford1, J M Boss.   

Abstract

We present here an in vivo view of major histocompatibility complex (MHC) class II promoter assembly, nucleosome modifications and gene expression mediated by the class II transactivator (CIITA). Acetylation and deacetylation of histones H3 and H4 at the HLA-DRA promoter were found to occur during a time-course that depended on CIITA expression and binding. Expression of a CIITA mutant, which lacked the activation domain, induced H4 but not H3 histone acetylation. This suggested that multiple histone acetyltransferase activities are associated with MHC class II expression. H4 acetylation was mapped to Lys8, which implicated several histone acetyltransferases as possible modulators of this activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429551     DOI: 10.1038/89810

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  75 in total

1.  Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.

Authors:  Krzysztof Masternak; Walter Reith
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

2.  Dynamics of global histone acetylation and deacetylation in vivo: rapid restoration of normal histone acetylation status upon removal of activators and repressors.

Authors:  Yael Katan-Khaykovich; Kevin Struhl
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

3.  CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II.

Authors:  Charalambos Spilianakis; Androniki Kretsovali; Theodora Agalioti; Takis Makatounakis; Dimitris Thanos; Joseph Papamatheakis
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

4.  Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.

Authors:  Ben Youngblood; Kenneth J Oestreich; Sang-Jun Ha; Jaikumar Duraiswamy; Rama S Akondy; Erin E West; Zhengyu Wei; Peiyuan Lu; James W Austin; James L Riley; Jeremy M Boss; Rafi Ahmed
Journal:  Immunity       Date:  2011-09-23       Impact factor: 31.745

5.  A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520.

Authors:  Soham D Puvvada; Hongli Li; Lisa M Rimsza; Steven H Bernstein; Richard I Fisher; Michael LeBlanc; Monika Schmelz; Betty Glinsmann-Gibson; Thomas P Miller; Anne-Marie Maddox; Jonathan W Friedberg; Sonali M Smith; Daniel O Persky
Journal:  Leuk Lymphoma       Date:  2016-01-12

6.  Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursors.

Authors:  Shutao Mei; Rochelle Ayala; Sri H Ramarathinam; Patricia T Illing; Pouya Faridi; Jiangning Song; Anthony W Purcell; Nathan P Croft
Journal:  Mol Cell Proteomics       Date:  2020-05-01       Impact factor: 5.911

7.  New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.

Authors:  Michal Krawczyk; Krzysztof Masternak; Madeleine Zufferey; Emmanuèle Barras; Walter Reith
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

8.  Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

Authors:  Lisa M Rimsza; Robin A Roberts; Elias Campo; Thomas M Grogan; Silvia Bea; Itziar Salaverria; Andreas Zettl; Andreas Rosenwald; German Ott; H Konrad Muller-Hermelink; Jan Delabie; Richard I Fisher; Joseph M Unger; Michael Leblanc; Louis M Staudt; Elaine S Jaffe; Randy D Gascoyne; Wing C Chan; Dennis D Weisenburger; Timothy Greiner; Rita M Braziel; Thomas P Miller
Journal:  Blood       Date:  2005-10-20       Impact factor: 22.113

9.  The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity.

Authors:  Torsten B Meissner; Amy Li; Yuen-Joyce Liu; Etienne Gagnon; Koichi S Kobayashi
Journal:  Biochem Biophys Res Commun       Date:  2012-01-28       Impact factor: 3.575

10.  Regulation of acetylation at the major histocompatibility complex class II proximal promoter by the 19S proteasomal ATPase Sug1.

Authors:  Olivia I Koues; R Kyle Dudley; Agnieszka D Truax; Dawson Gerhardt; Kavita P Bhat; Sam McNeal; Susanna F Greer
Journal:  Mol Cell Biol       Date:  2008-07-28       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.